UniDoc Health Corp. (CSE: UDOC) (FRA: L7T) (OTCQB: UDOCF) announced on September 8, 2026 the closing of a non-brokered private placement of non-transferable unsecured convertible debentures, raising aggregate gross proceeds of $100,000. The debentures carry a 6.0% annual interest rate and mature on September 4, 2028. The announcement follows a prior news release dated July 17, 2026, and investors in the Vancouver-based eHealth company may be watching how the proceeds support near-term operations.

Key Points

  • UniDoc Health Corp. (CSE: UDOC) closed a non-brokered convertible debenture private placement on September 8, 2026
  • Aggregate gross proceeds of $100,000 raised; debentures bear 6.0% annual interest and mature September 4, 2028
  • The company retains the option to prepay or convert debentures into units upon a qualifying Future Financing Event
  • Proceeds are designated for working capital and general corporate purposes; all issued securities are subject to a four-month statutory hold

Debenture Terms and UniDoc's Prepayment Flexibility

The convertible debentures issued by UniDoc Health Corp. mature on September 4, 2028, and carry a fixed interest rate of 6.0% per annum. The company disclosed that it retains the option to prepay all or any portion of the debentures in cash prior to the maturity date. This flexibility gives management the ability to manage its repayment obligations depending on the company's liquidity position over the two-year term, though no specific prepayment schedule or triggers were outlined in the announcement.

Conversion Mechanism Tied to Future Financing Events

A key structural feature of the debentures is the conversion provision linked to any qualifying Future Financing Event. If UniDoc completes a subsequent private placement or public offering of common shares, units, subscription receipts, special warrants, or convertible debt, the company may, at its sole discretion, satisfy its repayment obligation by converting the debentures into units comprised of one common share and one common share purchase warrant. The conversion price per unit will equal the price of securities issued in the selected Future Financing Event, subject to a minimum price permitted under CSE policies.

Warrant Terms Under the Conversion Structure

The release states that if the qualifying Future Financing Event includes units with warrants, the warrants issued upon conversion will mirror the exercise price and expiry date of those warrants. If the selected Future Financing Event does not include warrants, the warrants issued to debenture holders will carry a three-year term from the date of issuance and an exercise price equal to the market price of UniDoc's common shares at the time the Future Financing Event is announced. All debentures and any securities issuable upon conversion are subject to a four-month statutory hold under Canadian securities laws.